Security

DXR · DAXOR CORP

DXRNASDAQCommon stockCurrentCIK 27367Updated Sep 26, 2026

Company: DAXOR CORP →

DXR price & chart

Provider market data

Loading TradingView…

NASDAQ:DXR on TradingView ↗

TradingView · Data may be delayed

In the news

Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference ↗

GlobeNewswire · 2026-09-08

Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions ↗

GlobeNewswire · 2026-03-17

Seeking Alpha

Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript ↗

Seeking Alpha · 2026-03-10

Daxor reports FY results ↗

Seeking Alpha · 2026-03-03

SEC disclosures

DAXOR CORP files 8-K: Material Event ↗

SEC · 2026-06-24

DAXOR CORP files definitive proxy statement ↗

SEC · 2026-06-03

Recent filings

N-CEN/A filing
N-CEN/A · 2026-09-24 · 0001493152-26-044184
40-8F-2/A filing
40-8F-2/A · 2026-09-04 · 0000897069-26-001752
NPORT-P filing
NPORT-P · 2026-08-31 · 0001493152-26-040882
N-CSR filing
N-CSR · 2026-08-31 · 0001493152-26-040876
N-PX filing
N-PX · 2026-08-31 · 0001493152-26-040701

Show 5 more recent filings

4 filing
4 · 2026-06-25 · 0001493152-26-030180
Submission of Matters to a Vote of Security Holders
Items 5.07
8-K · 2026-06-24 · 0001493152-26-029924
40-8F-2/A filing
40-8F-2/A · 2026-06-17 · 0000897069-26-001429
DEF 14A filing
DEF 14A · 2026-06-03 · 0001493152-26-027066
NT NPORT-P filing
NT NPORT-P · 2026-06-02 · 0001493152-26-026717

Financials

FY 2011 · USD

Revenue1,446,345USD · FY 2011

Source

10-K · 2012-03-28 · 0001019056-12-000401

2011-01-01 to 2011-12-31

Net income-7,185,639USD · FY 2011

Source

10-K · 2012-03-28 · 0001019056-12-000401

2011-01-01 to 2011-12-31

Assets85,724,861USD · FY 2011

Source

10-K · 2012-03-28 · 0001019056-12-000401

As of 2011-12-31

Cash59,625USD · FY 2011

Source

10-K · 2012-03-28 · 0001019056-12-000401

As of 2011-12-31

Operating income-5,786,414USD · FY 2011

Source

10-K · 2012-03-28 · 0001019056-12-000401

2011-01-01 to 2011-12-31

Diluted EPS— · FY 2011

Some figures are unavailable for this reporting year.

balance sheet · annual statements

Line item	FY 2011	FY 2010
ASSETS
AssetsUSD	85,724,861 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	91,195,415 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Property, Plant and Equipment, NetUSD	4,001,351 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	4,168,992 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD	59,625 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	57,741 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Accounts Receivable, after Allowance for Credit Loss, CurrentUSD	219,684 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	178,820 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Inventory, NetUSD	301,534 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	363,634 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Assets, CurrentUSD	81,686,352 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	86,989,265 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Prepaid Expense and Other Assets, CurrentUSD	209,339 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	130,560 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Other Assets, NoncurrentUSD	37,158 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	37,158 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
LIABILITIES AND EQUITY
LiabilitiesUSD	49,508,270 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	44,200,371 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Stockholders’ equity:
Common Stock, Value, IssuedUSD	53,165 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	53,165 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Additional Paid in CapitalUSD	10,684,752 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	10,675,228 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Retained Earnings (Accumulated Deficit)USD	24,740,252 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	32,980,341 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Accumulated Other Comprehensive Income (Loss), Net of TaxUSD	12,572,514 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	14,890,272 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Stockholders' Equity Attributable to ParentUSD	36,216,591 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	46,995,044 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Liabilities and EquityUSD	85,724,861 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	91,195,415 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31
Current liabilities:
Liabilities, CurrentUSD	49,264,316 Source 10-K · 2012-03-28 · 0001019056-12-000401 As of 2011-12-31	43,900,308 Source 10-Q/A · 2011-08-31 · 0001019056-11-000884 As of 2010-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements

Line item	FY 2011	FY 2010
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD	9,731 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	—
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD	-45,864 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	28,814 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Increase (Decrease) in InventoriesUSD	62,100 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	90,773 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Deferred Income Tax Expense (Benefit)USD	1,249,624 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	606,363 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Net Cash Provided by (Used in) Operating ActivitiesUSD	-6,508,648 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-5,690,083 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD	-11,388,438 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	9,401,925 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Payments to Acquire Property, Plant, and EquipmentUSD	123,150 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	324,710 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD	17,898,970 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-3,931,189 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Dividends paid	—	—
Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD	3,002,828 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	2,424,813 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Additional Financial Items
DepreciationUSD	290,791 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	296,554 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Income Tax Expense (Benefit)USD	-5,142,076 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	3,381,892 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Marketable Securities, Unrealized Gain (Loss)USD	-2,317,758 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-1,126,103 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Net Income (Loss) Attributable to ParentUSD	-7,185,639 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	4,968,264 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Nonoperating Income (Expense)USD	-6,541,301 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	14,009,267 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Operating ExpensesUSD	6,580,248 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	6,510,718 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Other Nonoperating Income (Expense)USD	-168,923 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-61,676 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Payments to Acquire InvestmentsUSD	25,722,529 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	28,856,997 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Unrealized Gain (Loss) on DerivativesUSD	-8,501,859 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-1,526,064 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements

Line item	FY 2011	FY 2010
Total RevenueUSD	1,446,345 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	1,579,257 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Cost of Goods and Services Sold	—	—
Selling, General and Administrative ExpenseUSD	3,874,296 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	3,469,078 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Operating Income (Loss)USD	-5,786,414 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-5,659,111 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Other Nonoperating Income (Expense)USD	-168,923 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	-61,676 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Income Tax Expense (Benefit)USD	-5,142,076 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	3,381,892 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Net Income (Loss) Attributable to ParentUSD	-7,185,639 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	4,968,264 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Additional Financial Items
Cost of Goods Sold (Deprecated 2018-01-31)USD	616,063 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	691,786 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Gross ProfitUSD	793,834 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	851,607 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Nonoperating Income (Expense)USD	-6,541,301 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	14,009,267 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Operating ExpensesUSD	6,580,248 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	6,510,718 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Other IncomeUSD	12,374 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	12,166 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31
Research and Development ExpenseUSD	2,705,952 Source 10-K · 2012-03-28 · 0001019056-12-000401 2011-01-01 to 2011-12-31	3,041,640 Source 10-K · 2012-03-28 · 0001019056-12-000401 2010-01-01 to 2010-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-281622

424B4 · 2026-01-26 · 0001493152-26-003486

Terms from the governing filing for this registration; not a claim that the offering is open today.

Gross proceeds: 9000006.0
Net proceeds: 8280006.0
Deal price: 11.75
Shares: 765958
Offering amount: $13.70
Offering price: $11.75
Ticker: DXR

Filing attachments

ex99-1.htm · 8-K · 2026-01-23

EX-99.1

8-K · 2026-01-23 · 0001493152-26-003302

Read attachment ↗

ex99-1.htm · 8-K · 2025-08-07

EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN - August 7, 2025 - Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces FDA 510(k) clearance (K251087) for its patent-pending next-generation rapid, compact, hand-held, lab-based Blood Volume Analyzer (…

8-K · 2025-08-07 · 0001641172-25-022513

Read attachment ↗